Delivery Order SPE2DB22D3004-SPE2DB24FRF56

Award Date 7/30/24
Potential Completion Date 7/31/24
Potential Value $1.4K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,625.39 firm fixed-price contract is for the delivery of CYANOKIT 5 gram vials, a specialty pharmaceutical product. The contract has an ultimate completion date of April 1, 2025. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of CYANOKIT 5 GRAM VL 1S, a medical product, with a ceiling value of $13,588.33 and a period of performance through July 29, 2025. The contract is designated as a firm fixed-price delivery order, with no set-aside used. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery...
This federal contract award, valued at $2,643.12, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for CYANOKIT 5 gram vials, a pharmaceutical product, with a period of performance through July 9, 2025. The award is not designated as a set-aside contract, indicating open competition. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract...
This is a $2,643.12 firm fixed-price delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the supply of 4568720486 CYANOKIT 5 GRAM VIALS, with a period of performance through July 8, 2025. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated as SPE2DX, which provides a comprehensive global pharmaceutical...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of CYANOKIT 5 gram vials. The delivery order is valued at $1,209.06 and has a firm fixed price pricing type. It is not a set-aside contract. AmerisourceBergen, a major pharmaceutical distributor, is the prime contractor and will provide these critical care medical supplies to support military treatment facilities and other federal healthcare programs. This delivery order is part...
Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Cencora Inc., has been awarded a $2,418.12 firm fixed price delivery order by the Defense Logistics Agency (DLA) Troop Support Medical to provide CYANOKIT 5 gram vials. This order is part of a larger indefinite delivery contract (IDC) awarded solely to Amerisourcebergen Drug Corp, with a potential value of up to $999,999,999.00 and a performance period through December 31, 2025. The IDC serves as the primary vehicle...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp for the supply of CYANOKIT 5 gram vials. The order has a ceiling value of $1,813.59 and is a firm fixed price contract. The order is part of a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical valued up to $999,999,999 through December 2025, which provides a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. This...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,303.85 firm-fixed-price delivery order is for CYANOKIT 5 gram vials, a medication used to treat cyanide poisoning. The contract has an ultimate completion date of July 1, 2025 and is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC)...
This award is a delivery order (SPE2DX24F1K5B) placed under an Indefinite Delivery Contract (SPE2DX15D2106) with the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of CYANOKIT 5 gram vials, a critical care pharmaceutical product, with a ceiling value of $1,209.06. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The contract is not set-aside and has an ultimate completion date of August 16, 2024. Amerisourcebergen...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,643.12 firm fixed-price delivery order is for 4567516677 CYANOKIT 5 GRAM VIALS, with a completion date of February 27, 2025. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB24FRF56
    Delivery Order

This is a delivery order award to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,358.48 contract is for the supply of CYANOKIT 5 gram vials, a critical care medication, with a period of performance ending on July 31, 2024. This award is not a set-aside contract. Amerisourcebergen holds a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at up to $999,999,999 through December 2025, which serves as a primary vehicle for delivering a comprehensive range of medical commodities to support military treatment programs and facilities worldwide. The company also holds an IDC with the Department of Justice Federal Bureau of Investigation, valued at up to $750,000 through May 2024, for similar medical products and prescription drugs.

Generated 10/29/24, 9:02 AM